For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Mersana Therapeutics, Inc.

USPTO Granted Patents = 36

EPO Patents = 12

Trademarks = 4

Forward Citations = 274

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Timothy B Lowinger (29 out of 48 patents)

Aleksandr V Yurkovetskiy (28 out of 31 patents)

Mao Yin (22 out of 25 patents)

4. Joshua D Thomas (19 out of 21 patents)

5. Cheri A Stevenson (18 out of 31 patents)

6. Natalya D Bodyak (17 out of 17 patents)

7. Patrick R Conlon (14 out of 28 patents)

8. Charles E Hammond (13 out of 13 patents)

9. Dmitry R Gumerov (11 out of 11 patents)

10. Eugene W Kelleher (7 out of 12 patents)

11. Dorin Toader (6 out of 6 patents)

12. Peter U Park (5 out of 31 patents)

13. Jeremy R Duvall (4 out of 4 patents)

14. Keith W Bentley (4 out of 4 patents)

15. Bingfan Du (4 out of 8 patents)

36 patents: Sort by Forward Citations

1. 12440576 - Antibody drug conjugates comprising sting agonists (2025-10-14),

2. 12156870 - Antibody drug conjugates comprising sting agonists (2024-12-03),

3. 11964025 - Peptide-containing linkers for antibody-drug conjugates (2024-04-23),

4. 11964024 - B7H4-targeted antibody-drug conjugates and methods of use thereof (2024-04-23),

5. 11939343 - Sting agonist compounds and methods of use (2024-03-26),

6. 11786605 - Site specific antibody-drug conjugates with peptide-containing linkers (2023-10-17),

7. 11638760 - Pyrrolobenzodiazepine antibody conjugates (2023-05-02),

8. 11596694 - Compositions and methods for predicting response to NaPi2b-targeted therapy (2023-03-07),

9. 11518812 - Monoclonal antibodies against HER2 epitope and methods of use thereof (2022-12-06),

10. 11407825 - NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof (2022-08-09),

11. 11155567 - Sting agonist compounds and methods of use (2021-10-26),

12. 11135307 - Peptide-containing linkers for antibody-drug conjugates (2021-10-05),

13. 10947317 - NaPi2b-targeted antibody-drug conjugates and methods of use thereof (2021-03-16),

14. 10660901 - Pyrrolobenzodiazepines and conjugates thereof (2020-05-26),

15. 10603386 - Protein-polymer-drug conjugates (2020-03-31),

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, highly differentiated antibody-drug conjugates (ADCs) to treat various forms of cancer. The company's proprietary drug platform, Fleximer®, enables the development of next-generation ADCs with enhanced potency, superior safety, and broader therapeutic potential. Mersana is committed to revolutionizing cancer treatment through the targeted delivery of potent payloads to tumor cells while sparing healthy tissue.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

36 Patents

#62 in Cambridge, MA

#539 in Massachusetts

#9,192 in US

#18,179 in the World

Cambridge, MA, United States of America

Mersana Therapeutics, Inc.

Forward Citations = 274

44 inventors:

Timothy B Lowinger (29 out of 48 patents)

Aleksandr V Yurkovetskiy (28 out of 31 patents)

Mao Yin (22 out of 25 patents)

4. Joshua D Thomas (19 out of 21 patents)

5. Cheri A Stevenson (18 out of 31 patents)

Please report any incorrect information to support@idiyas.com

Loading…